ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
A novel biallelic mutation in the DYSF gene as a cause of Miyoshi myopathy.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
background and purposeMiyoshi myopathy is an autosomal recessive distal myopathy resulting from pathogenic variants in the DYSF gene encoding dysferlin. This study aimed to characterize a novel biallelic DYSF gene mutation as a cause of Miyoshi myopathy through comprehensive clinical, genetic and pathological analysis.
methodsWe evaluated serum muscle enzymes and electromyography for myopathic features and performed muscle magnetic resonance imaging to characterize the pattern of involvement. We then conducted whole-exome sequencing with Sanger validation to identify potential causative variants and obtained a muscle biopsy for pathological confirmation.
resultsA 19-year-old male presented with progressive bilateral lower limb weakness and symmetric posterior calf muscles atrophy. Markedly elevated creatine kinase (18053 U/L) and myopathic electromyography supported a diagnosis of distal myopathy. Muscle imaging demonstrated severe gastrocnemius atrophy without inflammation. Whole-exome sequencing identified a novel homozygous nonsense variant in exon 20 of the DYSF gene (c.1851 C > G, p.Tyr617Ter), producing a premature stop codon. Muscle biopsy confirmed absent sarcolemmal dysferlin expression, supporting a loss-of-function mechanism.
conclusionWe reported a novel pathogenic variant in the DYSF gene, expanding the mutational spectrum of Miyoshi myopathy and reinforcing the role of biallelic DYSF mutations in disease inheritance.
Indexed as
Identifiers
42047868What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.